 |
40 Products |  |
109 Diseases | | 40 Products |
|
37 Trials |  |
1900 News |  |
| «12...891011121314151617181920» |
- | Zemimet SR (gemigliptin/metformin sustained release) / LG Chem
Trial completion: BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone. (clinicaltrials.gov) - May 6, 2014
P1, N=24, Completed, Sponsor: LG Life Sciences
Not yet recruiting --> Completed
- ||||| Fotivda (tivozanib) / Kyowa Kirin, AVEO, Jazz
Trial initiation date: A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols (clinicaltrials.gov) - May 1, 2014
P2/3, N=230, Ongoing, Sponsor: AVEO Pharmaceuticals, Inc.`AVEO PHARMACEUTICALS, INC.
Not yet recruiting --> Completed Initiation date: Jun 2010 --> Oct 2010
- ficlatuzumab (AV-299) / LG Chem
New P1 trial: Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML (clinicaltrials.gov) - Apr 8, 2014
P1, N=24, Active, not recruiting, Sponsor: C. Babis Andreadis
- | Espogen (epoetin alfa biosimilar) / LG Chem
Trial completion: Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1 (clinicaltrials.gov) - Apr 6, 2014
P1, N=11, Completed, Sponsor: MinYoung Kim, M.D.
Initiation date: Jun 2010 --> Oct 2010 Active, not recruiting --> Completed
- ||| Espogen (epoetin alfa biosimilar) / LG Chem
Trial initiation date: Erythropoietin Therapy for Children With Cerebral Palsy (clinicaltrials.gov) - Mar 30, 2014
P2, N=80, Not yet recruiting, Sponsor: Bundang CHA Hospital
Active, not recruiting --> Completed Initiation date: Jan 2014 --> Sep 2014
- ||| Shinbaro (GCSB-5) / GC Pharma, LG Chem
Enrollment open, Adverse events: A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule (clinicaltrials.gov) - Mar 25, 2014
P=N/A, N=6700, Recruiting, Sponsor: Green Cross Corporation
Initiation date: Jan 2014 --> Sep 2014 Not yet recruiting --> Recruiting
- | Pegasys (pegylated interferon α -2a) / Roche
New P4 trial: E+VIP: Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection (clinicaltrials.gov) - Mar 24, 2014
P4, N=150, Not yet recruiting, Sponsor: Seoul National University Hospital
- |||||||||| Hexaxim (DTaP-IPV-Hep B-Hib vaccine) / Sanofi
New P3 trial: DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants (clinicaltrials.gov) - Mar 20, 2014
P3, N=458, Recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
- ficlatuzumab (AV-299) / AVEO
Clinical: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient (clinicaltrials.gov) - Mar 16, 2014
P=N/A, N=0, Available, Sponsor: AVEO Pharmaceuticals, Inc.
- |||||||||| ZemiSU (gemigliptin/glimepiride) / LG Chem
New P3 trial: Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes (clinicaltrials.gov) - Mar 13, 2014
P3, N=230, Not yet recruiting, Sponsor: LG Life Sciences
- AV-203 / LG Chem
Enrollment closed, Metastases: A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Mar 13, 2014
P1, N=90, Active, not recruiting, Sponsor: AVEO Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||| MIT-001 / MitoImmune Therap
Trial completion: Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects (clinicaltrials.gov) - Mar 12, 2014
P1, N=89, Completed, Sponsor: LG Life Sciences
Recruiting --> Active, not recruiting Recruiting --> Completed
- |||||| Besivo (besifovir) / Gilead, LG Chem, Ildong
Enrollment open: Phase 3 and Extensional Study of Besifovir (clinicaltrials.gov) - Mar 11, 2014
P3, N=188, Recruiting, Sponsor: IlDong Pharmaceutical Co Ltd
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| ZemiStatin (gemigliptin/rosuvastatin FDC) / LG Chem
New P3 trial, Combination therapy: Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE) (clinicaltrials.gov) - Mar 3, 2014
P3, N=290, Recruiting, Sponsor: LG Life Sciences
- ||||| MIT-001 / MitoImmune Therap
New P2 trial: Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients (clinicaltrials.gov) - Feb 23, 2014
P2, N=60, Recruiting, Sponsor: LG Life Sciences
- Euvax B (recombinant hepatitis B vaccine) / LG Chem, Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
Enrollment closed: Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine (clinicaltrials.gov) - Feb 20, 2014
P1/2, N=350, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial termination, Combination therapy, IO biomarker, Metastases: BATON-BC: Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (clinicaltrials.gov) - Feb 18, 2014
P2, N=147, Terminated, Sponsor: AVEO Pharmaceuticals, Inc.
Recruiting --> Active, not recruiting Recruiting --> Terminated; low enrollment
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment open: Tivozanib As Maintenance Therapy In GYN (clinicaltrials.gov) - Feb 18, 2014
P2, N=60, Recruiting, Sponsor: Dana-Farber Cancer Institute
Recruiting --> Terminated; low enrollment Not yet recruiting --> Recruiting
- ||||||| Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial completion, Metastases: TIVO-1: A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma (clinicaltrials.gov) - Feb 18, 2014
P3, N=517, Completed, Sponsor: AVEO Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment closed: Tivozanib for Recurrent Glioblastoma (clinicaltrials.gov) - Feb 5, 2014
P2, N=21, Active, not recruiting, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Zemimet SR (gemigliptin/metformin sustained release) / LG Chem
New P1 trial: BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone. (clinicaltrials.gov) - Feb 4, 2014
P1, N=24, Not yet recruiting, Sponsor: LG Life Sciences
- ||||| Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment closed, P3 data: An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301). (clinicaltrials.gov) - Jan 22, 2014
P3, N=350, Active, not recruiting, Sponsor: AVEO Pharmaceuticals, Inc.
Recruiting --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
- |||| Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial completion, Metastases: TAURUS: A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC (clinicaltrials.gov) - Jan 22, 2014
P2, N=160, Completed, Sponsor: AVEO Pharmaceuticals, Inc.
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- | Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial completion: A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function (clinicaltrials.gov) - Jan 22, 2014
P1, N=44, Completed, Sponsor: AVEO Pharmaceuticals, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- | Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial completion, Combination therapy, Metastases: A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda (clinicaltrials.gov) - Jan 22, 2014
P1, N=24, Completed, Sponsor: AVEO Pharmaceuticals, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- | ficlatuzumab (AV-299) / LG Chem
Trial completion, Combination therapy, Monotherapy, Metastases: P05538: A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma (clinicaltrials.gov) - Jan 22, 2014
P1, N=41, Completed, Sponsor: AVEO Pharmaceuticals, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Eutropin Plus (somatropin SR) / LG Chem, Bioton
New P2 trial: Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients (clinicaltrials.gov) - Jan 20, 2014
P2, N=45, Not yet recruiting, Sponsor: LG Life Sciences
- |||||| Shinbaro (GCSB-5) / GC Pharma, LG Chem
Enrollment open: Efficacy of Shinabro in Hand Osteoarthritis (clinicaltrials.gov) - Dec 21, 2013
P2/3, N=220, Recruiting, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial withdrawal, Surgery: Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer (clinicaltrials.gov) - Dec 16, 2013
P=N/A, N=0, Withdrawn, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Recruiting Recruiting --> Withdrawn
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment change, Surgery: Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer (clinicaltrials.gov) - Dec 16, 2013
P=N/A, N=0, Withdrawn, Sponsor: Roswell Park Cancer Institute
Recruiting --> Withdrawn N=10 --> 0
- | Gemiglo (gemigliptin) / Sanofi, LG Chem
New P1 trial: Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers (clinicaltrials.gov) - Dec 5, 2013
P1, N=28, Recruiting, Sponsor: LG Life Sciences
- |||||||||| Gemiglo (gemigliptin) / Sanofi, LG Chem
New P3 trial: Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin (clinicaltrials.gov) - Nov 19, 2013
P3, N=174, Not yet recruiting, Sponsor: LG Life Sciences
- |||| Shinbaro (GCSB-5) / GC Pharma, LG Chem
Trial completion: To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis (clinicaltrials.gov) - Nov 10, 2013
P4, N=761, Completed, Sponsor: Green Cross Corporation
N=10 --> 0 Active, not recruiting --> Completed
- | Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
New P2 trial: Tivozanib As Maintenance Therapy In GYN (clinicaltrials.gov) - Oct 28, 2013
P2, N=60, Recruiting, Sponsor: Dana-Farber Cancer Institute
- ||||| Gemiglo (gemigliptin) / Sanofi, LG Chem
New P4 trial: A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study) (clinicaltrials.gov) - Oct 21, 2013
P4, N=148, Recruiting, Sponsor: LG Life Sciences
- | Zemimet SR (gemigliptin/metformin sustained release) / LG Chem
Trial completion: Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets) (clinicaltrials.gov) - Oct 21, 2013
P1, N=24, Completed, Sponsor: LG Life Sciences
Active, not recruiting --> Completed Enrolling by invitation --> Completed
- |||||||||| Besivo (besifovir) / Gilead, LG Chem, Ildong
New P3 trial: Phase 3 and Extensional Study of Besifovir (clinicaltrials.gov) - Sep 8, 2013
P3, N=188, Recruiting, Sponsor: IlDong Pharmaceutical Co Ltd
- | ZemiStatin (gemigliptin/rosuvastatin FDC) / LG Chem
Trial completion: Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin (clinicaltrials.gov) - Aug 26, 2013
P1, N=30, Completed, Sponsor: LG Life Sciences
Enrolling by invitation --> Completed Recruiting --> Completed
- ||| Rovatitan (rosuvastatin/valsartan) / LG Chem
New P1 trial: Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg (clinicaltrials.gov) - Aug 5, 2013
P1, N=60, Completed, Sponsor: LG Life Sciences
- ||| Rovatitan (rosuvastatin/valsartan) / LG Chem
Trial completion: Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg (clinicaltrials.gov) - Aug 5, 2013
P1, N=60, Completed, Sponsor: LG Life Sciences
Recruiting --> Completed Not yet recruiting --> Completed
- |||||||||| Shinbaro (GCSB-5) / GC Pharma, LG Chem
New P2/3 trial: Efficacy of Shinabro in Hand Osteoarthritis (clinicaltrials.gov) - Jul 25, 2013
P2/3, N=220, Recruiting, Sponsor: Seoul National University Hospital
- Gemiglo (gemigliptin) / Sanofi, LG Chem
Enrollment open: Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects (clinicaltrials.gov) - Jul 23, 2013
P1, N=30, Enrolling by invitation, Sponsor: LG Life Sciences
Not yet recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- Xtandi (enzalutamide capsule) / Pfizer, Astellas, Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment open, Metastases: Tivozanib + Enzalutamide in Adv Prostate Cancer (clinicaltrials.gov) - Jul 14, 2013
P2, N=42, Recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting
- Fotivda (tivozanib) / Kyowa Kirin, AVEO, Jazz
Enrollment open, Surgery, Metastases: Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery (clinicaltrials.gov) - Jul 11, 2013
P1/2, N=49, Recruiting, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||||| Eutravac (diphtheria-tetanus-acellular pertussis [DTaP] hepatitis B [HB] combined vaccine) / LG Chem
New P3 trial: A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants (clinicaltrials.gov) - Jul 9, 2013
P3, N=289, Completed, Sponsor: LG Life Sciences
- ||||||| Eutravac (diphtheria-tetanus-acellular pertussis [DTaP] hepatitis B [HB] combined vaccine) / LG Chem
Trial completion: A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants (clinicaltrials.gov) - Jul 7, 2013
P3, N=289, Completed, Sponsor: LG Life Sciences
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- Fotivda (tivozanib) / Kyowa Kirin, AVEO, Jazz
Trial initiation date, Surgery, Metastases: Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery (clinicaltrials.gov) - Jul 2, 2013
P1/2, N=49, Recruiting, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Completed Initiation date: Apr 2013 --> Jul 2013
- Xtandi (enzalutamide capsule) / Pfizer, Astellas, Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
New P2 trial, Metastases: Tivozanib + Enzalutamide in Adv Prostate Cancer (clinicaltrials.gov) - Jun 23, 2013
P2, N=42, Recruiting, Sponsor: Massachusetts General Hospital
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial withdrawal, Metastases: A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat (clinicaltrials.gov) - Jun 20, 2013
P1/2, N=0, Withdrawn, Sponsor: University of Utah
Initiation date: Apr 2013 --> Jul 2013 Not yet recruiting --> Withdrawn
- Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Enrollment change, Metastases: A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat (clinicaltrials.gov) - Jun 20, 2013
P1/2, N=0, Withdrawn, Sponsor: University of Utah
Not yet recruiting --> Withdrawn N=170 --> 0